Global Viscosupplementation Market Research Report 2018-2023
Summary – A new market study, “Global Viscosupplementation Market Research and Forecast, 2018-2023 ”has been featured on WiseGuyReports.
Viscosupplementation is a medical procedure used for the
treatment of osteoarthritis symptoms. It is a non-invasive procedure under
which lubricating fluid is injected into joints, which is also referred to as
hyaluronic acid injections. It is intended to reduce joint pain and improves
the condition of osteoarthritis joints, including knee, hip, ankle, shoulder,
spine, wrist, and elbow. A significant rise in the prevalence of osteoarthritis
has witnessed over the last decade. For instance, according to the Arthritis
Foundation, an estimated 30.8 million adults in the US had osteoarthritis in
2015. It represents that osteoarthritis is the most common cause of disability
among adults. These factors significantly increase the demand for the efficient
procedure to treat osteoarthritis condition. This, in turn, is driving the
adoption of viscosupplementation as it is one of the effective procedures to
reduce joint pain and treatment of the condition.
Other factors that are encouraging the market growth include
growing sports-related injuries, adoption of non-invasive procedures and
increasing demand for knee osteoarthritis. Additionally, improving healthcare
infrastructure and growing awareness about viscosupplementation is expected to
offer a remarkable opportunity for the growth of the global
viscosupplementation market. However, there are certain factors restricting the
market growth comprising stringent regulations and adverse effects associated with
viscosupplementation.
Furthermore, the global viscosupplementation market is segmented
into application and products. Based on application, the market is classified
into the knee, hip, ankle, shoulder, and spine. The demand for
viscosupplementation in knee osteoarthritis is growing significantly due to its
effectiveness to provide relief to the patients. Viscosupplementation for knee
procedure is particularly useful for people who have not relieved from physical
therapy, weight loss, and corticosteroid injections. Therefore, it is
considered to be the most efficient method for the treatment of knee
osteoarthritis which in turn is boosting the market. Based on the product, the
market is classified into single-injection, three-injection, and five-injection.
On the basis of geography, the global viscosupplementation
market is segmented into four major regions, including North America, Europe,
Asia-Pacific, and Rest of the World. North America is gaining significant share
in the global viscosupplementation market due to rising incidences of
osteoarthritis in the US and Canada. Europe is also the major contributor to
the market growth due to the high focus on providing patient-centered quality
care in the region.
Some key companies of the global viscosupplementation market
include Dr. Reddy’s Laboratories Ltd., Anika Therapeutics, Inc., LG Life
Sciences Ltd., Smith & Nephew Plc. and Zimmer Biomet Holdings, Inc. These
companies adopt various strategies such as mergers & acquisition and
product launches to be competitive in the market. in addition, the companies
are receiving approval by the regulatory authorities for the launch of their
product. For instance, In October 2017, Anika Therapeutics, Inc. has gained
approval for MONOVISC in Australia. It is a single-injection
viscosupplementation used for the treatment of osteoarthritis pain of all
synovial joints which include knee and hip. This intends to further expand the
availability of MONOVISC in the global markets.
Research Methodology
The market study of the global viscosupplementation market is
incorporated by extensive primary and secondary research conducted by the
research team at OMR. Secondary research has been conducted to refine the
available data to break down the market in various segments, derive total
market size, market forecast, and growth rate. Different approaches have been
worked on to derive the market value and market growth rate. Our team collects
facts and data related to the market from different geography to provide a
better regional outlook. In the report, a country-level analysis is provided by
analyzing various regional players, regional tax laws and policies, consumer behavior
and macroeconomic factors. Numbers extracted from Secondary research have been
authenticated by conducting proper primary research. It includes tracking down
key people from the industry and interviewing them to validate the data. This
enables our analyst to derive the closest possible figures without any major
deviations in the actual number. Our analysts try to contact as many
executives, managers, key opinion leaders, and industry experts. Primary
research brings the authenticity of our reports.
Secondary Sources Include:
Financial reports of companies involved in the market
Authentic Public Databases such as Centers for Disease Control and Prevention,
Arthritis Foundation and others.
Whitepapers, research-papers, and news blogs
Company websites and their product catalog
The report is intended for healthcare providers and government organizations
for overall market analysis and competitive analysis. The report will serve as
a source for 360-degree analysis of the market thoroughly delivering insights
into the market for better business decisions.
Market Segmentation:
Global Viscosupplementation Market is segmented on the basis of
regional outlook and following segments:
Global Viscosupplementation Market Research and Analysis, By
Application
Global Viscosupplementation Market Research and Analysis, By Product
Global Viscosupplementation Market Research and Analysis, By Region
The Report Covers:
Comprehensive research methodology of global viscosupplementation
market.
This report also includes a detailed and extensive market overview with key
analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided
by key recommendations.
Analysis of regional regulations and other government policies impacting the
global viscosupplementation market.
Insights about market determinants which are stimulating the
global viscosupplementation marketCompanies Mentioned
1. Anika Therapeutics, Inc.
2. Depuy Synthes, Inc.
3. Dr. Reddy’s Laboratories Ltd.
4. Ferring Pharmaceuticals B.V.
5. Fidia Farmaceutici S.p.A.
6. KalVista Pharmaceuticals, Inc.
7. LG Life Sciences, Ltd.
8. Lifecore Biomedical, LLC
9. Maxigen Biotech, Inc.
10. PendoPharm Inc.
11. Regen Lab SA
12. Sanofi-Aventis US LLC
13. Seikagaku Corporation
14. Shanghai Haohai Biological Technology Co., Ltd.
15. Smith & Nephew PLC.
16. Stellar Pharmaceuticals, Inc.
17. Stryker Corporation
18. Swiss Biomed Orthopaedics AG
19. Virchow Biotech Pvt. Ltd.
20. Zimmer Biomet Holdings, Inc.
About Us:
Wise Guy Reports is part of the Wise Guy Research
Consultants Pvt. Ltd. and offers premium progressive
statistical surveying, market research reports, analysis
& forecast data for industries and governments
around the globe.
Contact Us:
NORAH TRENT
sales@wiseguyreports.com
Ph: +162-825-80070
(US)
Ph: +44 2035002763 (UK)
Comments
Post a Comment